This HTML5 document contains 52 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB01429/identifier/pubchem-compound/
n14http://linked.opendata.cz/resource/mesh/concept/
n8http://linked.opendata.cz/resource/drugbank/drug/DB01429/identifier/pubchem-substance/
n9http://linked.opendata.cz/resource/drugbank/drug/DB01429/identifier/kegg-drug/
n12http://linked.opendata.cz/resource/drugbank/drug/DB01429/identifier/drugbank/
n17http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB01429/identifier/chemspider/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n13http://linked.opendata.cz/ontology/mesh/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n16http://linked.opendata.cz/resource/drugbank/drug/DB01429/identifier/wikipedia/
xsdhhttp://www.w3.org/2001/XMLSchema#
n15http://linked.opendata.cz/resource/drugbank/drug/DB01429/identifier/pharmgkb/
n20http://linked.opendata.cz/resource/atc/
n19http://linked.opendata.cz/ontology/sukl/drug/

Statements

Subject Item
n2:DB01429
rdf:type
n3:Drug
n3:description
A cardiac depressant used in arrhythmias. [PubChem]
n3:group
approved
owl:sameAs
n6:DB01429 n17:DB01429
dcterms:title
Aprindine
adms:identifier
n8:46505478 n9:D01326 n10:2218 n11:2132 n12:DB01429 n15:PA164764496 n16:Aprindine
n3:synonym
SID50112831 Aprindina Compound 99170 SID90340712 Aprindine Aprindinum
n3:salt
n3:synthesisReference
Vanhoof, P. and Clarebout, P.; British Patent 1,321,424; June 27, 1973; assigned to Manufac- ture de Produits Pharmaceutiques A. Christiaens, SA
n13:hasConcept
n14:M0001626
n3:IUPAC-Name
n4:271B49E8-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B49EE-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B49ED-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B49EA-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B49EB-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B49EC-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B49E6-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B49E4-363D-11E5-9242-09173F13E4C5 n4:271B49E7-363D-11E5-9242-09173F13E4C5 n4:271B49FE-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B49E5-363D-11E5-9242-09173F13E4C5
n19:hasATCCode
n20:C01BB04
n3:H-Bond-Acceptor-Count
n4:271B49F4-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B49F5-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B49EF-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B49F0-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B49F2-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B49F1-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B49F3-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
37640-71-4
n3:category
n3:Bioavailability
n4:271B49F9-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B49FB-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B49FC-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B49FD-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B49F8-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B49F7-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B49FA-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B49E9-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B49F6-363D-11E5-9242-09173F13E4C5